Jfs Wealth Advisors, LLC Neurocrine Biosciences Inc Transaction History
Jfs Wealth Advisors, LLC
- $1.47 Billion
- Q1 2025
A detailed history of Jfs Wealth Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 19 shares of NBIX stock, worth $2,337. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 39
51.28%
Holding current value
$2,337
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.22 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$681 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$598 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$329 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...